Oseaspre Consultants Ltd
₹
- close price
About
Oseaspre Consultants engaged in the business of provision of technical know-how or rendering of services in connection with the provision of technical know how and to provide services in areas of accountancy and secretarial, etc.
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 5.88 %
- ROE 5.88 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Company has a low return on equity of -7.57% over last 3 years.
- Company has high debtors of 385 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.24 | 0.24 | 0.07 | 0.06 | 0.07 | 0.05 | 0.03 | 0.04 | 0.04 | 0.00 | 0.18 | 0.18 | |
| 0.04 | 0.04 | 0.17 | 0.12 | 0.12 | 0.13 | 0.16 | 0.12 | 0.14 | 0.13 | 0.19 | 0.18 | 0.20 | |
| Operating Profit | -0.03 | 0.20 | 0.07 | -0.05 | -0.06 | -0.06 | -0.11 | -0.09 | -0.10 | -0.09 | -0.19 | 0.00 | -0.02 |
| OPM % | -300.00% | 83.33% | 29.17% | -71.43% | -100.00% | -85.71% | -220.00% | -300.00% | -250.00% | -225.00% | 0.00% | -11.11% | |
| 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.07 | 0.05 | 0.05 | 0.05 | 0.02 | 0.05 | 0.04 | 0.04 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.23 | 0.10 | -0.02 | -0.03 | 0.01 | -0.06 | -0.04 | -0.05 | -0.07 | -0.14 | 0.04 | 0.02 |
| Tax % | 17.39% | 20.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| 0.00 | 0.18 | 0.08 | -0.02 | -0.03 | 0.01 | -0.06 | -0.04 | -0.05 | -0.07 | -0.14 | 0.04 | 0.02 | |
| EPS in Rs | |||||||||||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 29% |
| 3 Years: | 65% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | 22% |
| 3 Years: | 41% |
| TTM: | 113% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -6% |
| 3 Years: | -8% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Reserves | 0.60 | 0.78 | 0.86 | 0.91 | 0.87 | 0.88 | 0.76 | 0.72 | 0.67 | 0.60 | 0.46 | 0.50 | 0.42 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.05 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.02 | |
| Total Liabilities | 0.81 | 1.03 | 1.07 | 1.13 | 1.09 | 1.10 | 0.97 | 0.93 | 0.88 | 0.81 | 0.69 | 0.73 | 0.64 |
| 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.74 | 0.29 | 0.00 | 0.08 | 0.07 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 |
| 0.06 | 0.73 | 1.06 | 1.04 | 1.01 | 1.02 | 0.96 | 0.92 | 0.87 | 0.80 | 0.68 | 0.72 | 0.27 | |
| Total Assets | 0.81 | 1.03 | 1.07 | 1.13 | 1.09 | 1.10 | 0.97 | 0.93 | 0.88 | 0.81 | 0.69 | 0.73 | 0.64 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | 0.02 | -0.20 | -0.10 | -0.09 | -0.07 | -0.11 | -0.07 | -0.09 | -0.11 | -0.19 | -0.19 | |
| 0.02 | 0.69 | -0.04 | -0.36 | 0.14 | 0.04 | 0.07 | 0.11 | 0.08 | 0.07 | 0.28 | 0.11 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | 0.00 | 0.70 | -0.23 | -0.46 | 0.05 | -0.03 | -0.04 | 0.04 | -0.01 | -0.04 | 0.08 | -0.08 |
| Free Cash Flow | -0.02 | 0.02 | -0.20 | -0.10 | -0.09 | -0.07 | -0.11 | -0.07 | -0.09 | -0.11 | -0.19 | -0.19 |
| CFO/OP | 67% | 10% | -200% | 200% | 150% | 100% | 100% | 78% | 90% | 122% | 100% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 385.28 | |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 385.28 | |
| Working Capital Days | 1,095.00 | -60.83 | 0.00 | 0.00 | 0.00 | 52.14 | 73.00 | 0.00 | 273.75 | 182.50 | 425.83 | |
| ROCE % | 0.00% | 25.84% | 9.80% | -1.84% | -2.75% | 0.93% | -5.88% | -4.26% | -5.59% | -8.38% | -19.18% | 5.88% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|
| Leasable Area (Investment Property) sq. feet |
|
||||
| Annual Rent Received INR |
|||||
| Capacity Utilization (Leased Status) % |
|||||
| Number of Permanent Employees Numbers |
|||||
Requires Premium
Requires Premium
Documents
Announcements
-
Closure of Trading Window
26 Mar - Trading window closed 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
25 Feb - Sold 48,000 INOR Medical Products Ltd shares to Nowrosjee Wadia & Sons on Feb 25, 2026.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
14 Feb - Extract of unaudited Q3 and nine months financial results for period ended 31 Dec 2025 published 14 Feb 2026.
-
Results For The Third Quarter And Nine Months Ended 31St December, 2025
12 Feb - Unaudited Q3 and nine-month results to 31-Dec-2025: Q3 loss ₹3.90L, nine-month loss ₹11.80L, no revenue.
-
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING OF OSEASPRE CONSULTANTS LIMITED HELD ON 12TH FEBRUARY, 2026.
12 Feb - Unaudited Q3 and nine-month results ended 31 Dec 2025: Q3 loss ₹3.90L, nine-month loss ₹11.80L.
Annual reports
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse